Clinical Trial

A New Theory of Electrophysiological Mechanism of Atrial Fibrillation

Study acronym: ANTEMAF
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 9, 2024 (before its estimated October 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
The electrophysiological mechanisms of atrial fibrillation remain disagreements. The goal of this clinical trail is to propose a new electrophysiological mechanism hypothesis of atrial fibrillation（AF）,meanwhile, the investigators sought to test the hypothesis that the superposition electrograms (SPEs) recorded during atrial fibrillation could be used as target sites for catheter ablation of atrial fibrillation.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05845034
Lead Sponsor The Second Affiliated Hospital of Kunming Medical University
Conditions Atrial Fibrillation
Enrollment 100 participants
Start Date 2023-04-01
Primary Completion 2024-10-30 (estimated)
Study Completion 2025-03-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-09